CHC Healthcare Group
CHC Healthcare Group, together with its subsidiaries, trades in medical equipment, pharmaceutical products, and health food in Taiwan, China, and internationally. The company is also involved in the leasing, installing, servicing, and repairing of medical instruments for use in various specialties, such as radiation oncology, medical imaging, neurology, surgery, ophthalmology, robot rehabilitatio… Read more
CHC Healthcare Group (4164) - Total Liabilities
Latest total liabilities as of September 2025: NT$6.86 Billion TWD
Based on the latest financial reports, CHC Healthcare Group (4164) has total liabilities worth NT$6.86 Billion TWD as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
CHC Healthcare Group - Total Liabilities Trend (2009–2024)
This chart illustrates how CHC Healthcare Group's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
CHC Healthcare Group Competitors by Total Liabilities
The table below lists competitors of CHC Healthcare Group ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Bintulu Port Holdings Bhd
KLSE:5032
|
Malaysia | RM1.36 Billion |
|
Prim S.A.
MC:PRM
|
Spain | €75.24 Million |
|
Gansu Mogao Industrial Development Co Ltd
SHG:600543
|
China | CN¥222.86 Million |
|
Capital Limited
PINK:CAPFF
|
USA | $250.37 Million |
|
Saha Pathanapibul Public Company Limited
BK:SPC
|
Thailand | ฿9.88 Billion |
|
Kitex Garments Limited
NSE:KITEX
|
India | ₹15.29 Billion |
|
ECB Bancorp Inc.
NASDAQ:ECBK
|
USA | $1.43 Billion |
|
Stellar V Capital Corp. Unit
NASDAQ:SVCCU
|
USA | $5.37 Million |
Liability Composition Analysis (2009–2024)
This chart breaks down CHC Healthcare Group's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.17 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.91 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.46 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how CHC Healthcare Group's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for CHC Healthcare Group (2009–2024)
The table below shows the annual total liabilities of CHC Healthcare Group from 2009 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | NT$7.51 Billion | +9.82% |
| 2023-12-31 | NT$6.84 Billion | +6.38% |
| 2022-12-31 | NT$6.43 Billion | +2.79% |
| 2021-12-31 | NT$6.25 Billion | +12.80% |
| 2020-12-31 | NT$5.54 Billion | -5.85% |
| 2019-12-31 | NT$5.89 Billion | +3.04% |
| 2018-12-31 | NT$5.71 Billion | +0.63% |
| 2017-12-31 | NT$5.68 Billion | +17.96% |
| 2016-12-31 | NT$4.81 Billion | +10.90% |
| 2015-12-31 | NT$4.34 Billion | +48.62% |
| 2014-12-31 | NT$2.92 Billion | +32.10% |
| 2013-12-31 | NT$2.21 Billion | -22.17% |
| 2012-12-31 | NT$2.84 Billion | +11.38% |
| 2011-12-31 | NT$2.55 Billion | +43.62% |
| 2010-12-31 | NT$1.78 Billion | -8.85% |
| 2009-12-31 | NT$1.95 Billion | -- |